ArriVent BioPharma (AVBP) Shares Outstanding (Diluted) (2023 - 2026)
ArriVent BioPharma's Shares Outstanding (Diluted) came in at 47.61 million for Q2 2026, up 36.0% from 35.01 million a year earlier and up 5.6% from the prior quarter.
Powered by 
Analysis
ArriVent BioPharma (AVBP) Shares Outstanding (Diluted) (2023 - 2026) Analysis & Trends
For FY2025, ArriVent BioPharma's Shares Outstanding (Diluted) was 38.46 million, up 22.2% from FY2024.
- Going back by year, Shares Outstanding (Diluted) was 31.47 million in FY2024 and 2.14 million in FY2023.
- The Q2 2026 figure represents the highest quarterly Shares Outstanding (Diluted) in data going back to Q1 2023.
- Year-over-year, Shares Outstanding (Diluted) has increased for six consecutive quarters, with growth averaging 26.0% over the last six quarters.
- Business Quant data shows AVBP's Shares Outstanding (Diluted) at 45.07 million (Q1 2026), 38.46 million (Q4 2025) and 41.91 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 893.70 Mn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 2.44 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 1.56 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 544.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 5.70 Bn |
| 10 | ArriVent BioPharma | 1.37 Bn | 1.37 Bn | - | 47.61 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 47.61 Mn |
| Mar 31, 2026 | 45.07 Mn |
| Dec 31, 2025 | 38.46 Mn |
| Sep 30, 2025 | 41.91 Mn |
| Jun 30, 2025 | 35.01 Mn |
| Mar 31, 2025 | 33.90 Mn |
| Dec 31, 2024 | 31.47 Mn |
| Sep 30, 2024 | 33.58 Mn |
| Jun 30, 2024 | 33.50 Mn |
| Mar 31, 2024 | 25.05 Mn |
| Dec 31, 2023 | 2.14 Mn |
| Sep 30, 2023 | 2.61 Mn |
| Jun 30, 2023 | 2.00 Mn |
| Mar 31, 2023 | 1.29 Mn |
API Access
ArriVent BioPharma Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=AVBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "AVBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=AVBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();